PRDX4 and type 2 diabetes mellitus: Specifically, autoimmune-induced apoptosis of pancreatic β-cells (in T1DM) and fatty liver phenotypes and peripheral insulin resistance (in T2DM) were diminished upon PrxIV overexpression.